Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1127.39 (Glytoucan)

Id:c74d5742-fa1f-5f49-8dd6-e07a9ba8f9bc

Glytoucan:G75616TG

Results found

Linked to

	Label	Description
	1127.39 has motif 3-Sialyl-LN (type 2) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G78641QJ-GLYCOSEQ00029842 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58239DH-GLYCOSEQ00148345 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G41759HA-GLYCOSEQ00121802 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has motif 6-Sialyl-GalNAc Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G78945LF-GLYCOSEQ00089235 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G88990JZ-GLYCOSEQ00012609 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G50792NR-GLYCOSEQ00153670 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58239DH-GLYCOSEQ00148349 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G29065KQ-GLYCOSEQ00097831 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has motif 3-Sialyl-LN (type 2)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G78641QJ-GLYCOSEQ00029842 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58239DH-GLYCOSEQ00148345 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G41759HA-GLYCOSEQ00121802 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has motif 6-Sialyl-GalNAc

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G78945LF-GLYCOSEQ00089235 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G88990JZ-GLYCOSEQ00012609 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G50792NR-GLYCOSEQ00153670 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G58239DH-GLYCOSEQ00148349 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1127.39 has glycosequence GLYGEN.GLYCOSEQUENCE:G29065KQ-GLYCOSEQ00097831 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.